ArticleBMC infectious diseases2026
SALGINTR: development and early evaluation of a low-cost cloud-based digital participatory surveillance system for influenza-like Illness among physicians in Türkiye - a proof of concept.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundParticipatory surveillance complements sentinel influenza monitoring in high-income settings, yet no such platform has targeted physicians as both participants and clinical sentinels. We established SALGINTR, a digital, physician-driven participatory surveillance system for influenza-like illness (ILI), assembling an automated data collection and analysis pipeline from freely available cloud-based tools at a total infrastructure cost of approximately US $100.
methodsPhysicians across Türkiye were recruited via snowball sampling to provide weekly self-reports of ILI symptoms through an online platform ( www.salgin.com.tr ) during epidemiological weeks 40-52 of the 2025-26 influenza season. ECDC ILI case definition was applied, and independent ILI episodes were ascertained using a clinical-episode rule whereby consecutive symptomatic weeks attributed to the same agent were counted as a single episode. Temporal concordance with national sentinel surveillance was assessed by Pearson and Spearman correlation with moving-block bootstrap confidence intervals, lead-lag cross-correlation, and Bland-Altman agreement. Epidemic detection was evaluated using a panel of six aberration detection algorithms (EARS C1-C3, negative-binomial CUSUM, EWMA, empirical 95th percentile).
resultsOf 243 registered physicians, 197 (analytical cohort) contributed 1,484 respondent-weeks of observation. Cumulative ILI incidence was 50.8% (100/197), with 156 independent episodes identified from 190 symptomatic person-weeks using a clinical-episode definition. Season-level viral positivity was similar in the two streams (SALGINTR 17.3%, 95% CI 11.7-24.2, 27/156; sentinel 14.5%, 95% CI 12.8-16.2, 247/1,709). Weekly SALGINTR viral-systemic positivity was temporally concordant with sentinel surveillance under the pre-specified causal three-week moving average (Pearson r = 0.575, 95% CI 0.35 to 0.90; Spearman ρ = 0.747; pre-epidemic W40-W49 r = 0.886, 95% CI 0.38 to 0.94). Bland-Altman analysis indicated no significant systematic bias (mean difference + 4.6 pp; 95% limits of agreement - 18.3 to + 27.4 pp). Neither system produced any alarm during the ten pre-epidemic weeks, and alarm agreement across the window was substantial (Cohen's κ = 0.755; specification-curve median κ = 0.639 across 72 analytical choices). Lead-lag analysis identified no timing advantage in either direction (peak lag - 1 week; bootstrap CI - 2 to + 2 weeks).
conclusionsSALGINTR demonstrates that a physician-driven digital participatory surveillance system can generate ILI signals concordant with established sentinel surveillance, at minimal cost. This proof-of-concept supports integration of participatory surveillance as a complementary component within mosaic respiratory disease surveillance frameworks in middle-income settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.